Bluejay Diagnostics (BJDX) Cash from Financing Activities (2020 - 2026)
Bluejay Diagnostics recorded quarterly Cash from Financing Activities of $124096.0 in Q1 2026, down 96.66% quarter-over-quarter from $3.7 million in Q4 2025, and up 12698.58% year-over-year from N/an in Q1 2025.
Bluejay Diagnostics' Cash from Financing Activities history runs 6 years deep, the most recent figure standing at $124096.0 for Q1 2026.
- In Q1 2026, Cash from Financing Activities rose 12698.58% year-over-year to $124096.0; the TTM figure through Mar 2026 stood at $7.2 million (down 2.92% YoY), while the FY2025 annual figure was $7.1 million, down 30.63% from the prior year.
- Cash from Financing Activities came in at $124096.0 for Q1 2026 at Bluejay Diagnostics, down from $3.7 million in the prior quarter.
- In the past five years, Cash from Financing Activities ranged from a high of $7.6 million in Q2 2024 to a low of -$147861.0 in Q3 2024.
- A 4-year average of $1.4 million and a median of -$985.0 in 2025 frame the typical range for Cash from Financing Activities.
- On a YoY basis, Cash from Financing Activities climbed as much as 283122.25% in 2024 and fell as far as 112.57% in 2024.
- Bluejay Diagnostics' Cash from Financing Activities stood at -$3050.0 in 2023, then soared by 56.52% to -$1326.0 in 2024, then surged by 279980.24% to $3.7 million in 2025, then tumbled by 96.66% to $124096.0 in 2026.
- According to Business Quant data, Cash from Financing Activities over the past three periods registered $124096.0, $3.7 million, and -$1015.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 17.31 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | -1.51 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -2.09 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | -260.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -451.20 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -26.93 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | -25.00 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 21.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | -97.90 Mn |
| 10 | Bluejay Diagnostics | 572,394.44 | -3.11 Mn | - | 124,096.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 124,096.00 |
| Mar 31, 2026 | 124,096.00 |
| Dec 31, 2025 | 3.71 Mn |
| Dec 31, 2025 | 3.71 Mn |
| Sep 30, 2025 | -1,015.00 |
| Sep 30, 2025 | -1,015.00 |
| Jun 30, 2025 | 3.38 Mn |
| Jun 30, 2025 | 3.38 Mn |
| Mar 31, 2025 | -985.00 |
| Mar 31, 2025 | -985.00 |
| Dec 31, 2024 | -1,326.00 |
| Dec 31, 2024 | -1,326.00 |
| Sep 30, 2024 | -147,861.00 |
| Sep 30, 2024 | -147,861.00 |
| Jun 30, 2024 | 7.58 Mn |
| Jun 30, 2024 | 7.58 Mn |
| Mar 31, 2024 | 2.79 Mn |
| Mar 31, 2024 | 2.79 Mn |
| Dec 31, 2023 | -3,050.00 |
| Dec 31, 2023 | -3,050.00 |
| Sep 30, 2023 | 1.18 Mn |
| Sep 30, 2023 | 1.18 Mn |
| Jun 30, 2023 | -2,679.00 |
| Jun 30, 2023 | -2,679.00 |
| Mar 31, 2023 | -58,803.00 |
| Mar 31, 2023 | -58,803.00 |
| Dec 31, 2021 | 19.26 Mn |
| Dec 31, 2021 | 19.26 Mn |
| Sep 30, 2021 | 1.05 Mn |
| Sep 30, 2021 | 1.05 Mn |
| Jun 30, 2021 | 2.51 Mn |
| Jun 30, 2021 | 2.51 Mn |
| Mar 31, 2021 | -290,751.00 |
| Mar 31, 2021 | -290,751.00 |
| Dec 31, 2020 | 994,449.00 |
| Dec 31, 2020 | 994,449.00 |